About the Authors
- Anders W. Jørgensen
-
Affiliation The Nordic Cochrane Centre, Dept 7811, Rigshospitalet, Copenhagen, Denmark
- Lars H. Lundstrøm
-
Affiliation Copenhagen Trial Unit, Copenhagen Centre of Clinical Intervention Research, Dept 7812, Rigshospitalet, Copenhagen, Denmark
- Jørn Wetterslev
-
Affiliation Copenhagen Trial Unit, Copenhagen Centre of Clinical Intervention Research, Dept 7812, Rigshospitalet, Copenhagen, Denmark
- Arne Astrup
-
Affiliation Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Frederiksberg, Denmark
- Peter C. Gøtzsche
-
* E-mail: pcg@cochrane.dk
Affiliations The Nordic Cochrane Centre, Dept 7811, Rigshospitalet, Copenhagen, Denmark, Institute of Medicine and Surgery, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark
Competing Interests
This trial was supported by Johnson & Johnson Pharmaceutical Research and Development, LLP, the producer of topiramate, to conduct the clinical trial from which the data for this paper originated (see reference 10). Arne Astrup is currently consultant or member of advisory boards for a number companies, including: Arena Pharmaceuticals Inc., USA; Basic Research, USA; BioCare Copenhagen, DenmarK; Boehringer Ingelheim Pharma, Germany; Gelesis, USA; Novo Nordisk, Denmark; Pathway Genomics Corporation, USA; S-Biotek, Denmark; Twinlab, USA; Vivus Inc., USA. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: AWJ JW PCG. Performed the experiments: AA. Analyzed the data: AWJ LHL JW. Contributed reagents/materials/analysis tools: AA. Wrote the paper: AWJ. Contributed to writing the paper: LHL JW AA PCG.